FI990752A - Menetelmä fysostigmiinikarbamaattijohdannaisten valmistamiseksi fysostigmiinistä - Google Patents

Menetelmä fysostigmiinikarbamaattijohdannaisten valmistamiseksi fysostigmiinistä Download PDF

Info

Publication number
FI990752A
FI990752A FI990752A FI990752A FI990752A FI 990752 A FI990752 A FI 990752A FI 990752 A FI990752 A FI 990752A FI 990752 A FI990752 A FI 990752A FI 990752 A FI990752 A FI 990752A
Authority
FI
Finland
Prior art keywords
physostigmine
preparation
carbamate derivatives
derivatives
carbamate
Prior art date
Application number
FI990752A
Other languages
English (en)
Swedish (sv)
Other versions
FI990752A0 (fi
Inventor
George E Lee
Thomas B K Lee
Donna M Borek
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Priority to FI990752A priority Critical patent/FI990752A0/fi
Publication of FI990752A publication Critical patent/FI990752A/fi
Publication of FI990752A0 publication Critical patent/FI990752A0/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Cephalosporin Compounds (AREA)
  • Indole Compounds (AREA)
FI990752A 1992-07-21 1999-04-06 Menetelmä fysostigmiinikarbamaattijohdannaisten valmistamiseksi fysostigmiinistä FI990752A0 (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI990752A FI990752A0 (fi) 1992-07-21 1999-04-06 Menetelmä fysostigmiinikarbamaattijohdannaisten valmistamiseksi fysostigmiinistä

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US91871992A 1992-07-21 1992-07-21
FI933264A FI933264A (fi) 1992-07-21 1993-07-19 Foerfarande foer framstaellning av fysostigminkarbamatderivat fraon fysostigmin
FI990752A FI990752A0 (fi) 1992-07-21 1999-04-06 Menetelmä fysostigmiinikarbamaattijohdannaisten valmistamiseksi fysostigmiinistä

Publications (2)

Publication Number Publication Date
FI990752A true FI990752A (fi) 1999-04-06
FI990752A0 FI990752A0 (fi) 1999-04-06

Family

ID=25440831

Family Applications (2)

Application Number Title Priority Date Filing Date
FI933264A FI933264A (fi) 1992-07-21 1993-07-19 Foerfarande foer framstaellning av fysostigminkarbamatderivat fraon fysostigmin
FI990752A FI990752A0 (fi) 1992-07-21 1999-04-06 Menetelmä fysostigmiinikarbamaattijohdannaisten valmistamiseksi fysostigmiinistä

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FI933264A FI933264A (fi) 1992-07-21 1993-07-19 Foerfarande foer framstaellning av fysostigminkarbamatderivat fraon fysostigmin

Country Status (16)

Country Link
US (1) US5498726A (fi)
JP (2) JP2899502B2 (fi)
KR (1) KR940005629A (fi)
CN (1) CN1037443C (fi)
AU (1) AU660550B2 (fi)
CA (1) CA2100908A1 (fi)
CZ (1) CZ284321B6 (fi)
FI (2) FI933264A (fi)
HU (1) HU212600B (fi)
IL (1) IL106419A (fi)
MX (1) MX9304397A (fi)
NO (1) NO301276B1 (fi)
NZ (1) NZ248180A (fi)
PH (1) PH30885A (fi)
RU (1) RU2116307C1 (fi)
TW (1) TW239143B (fi)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5866120A (en) * 1995-11-22 1999-02-02 Advanced Corneal Systems, Inc. Method for accelerating clearance of hemorrhagic blood from the vitreous humor with hyaluronidase
US5665880A (en) * 1996-10-31 1997-09-09 Hoechst Marion Roussel, Inc. Method of preparation of physostigmine carbamate derivatives from eseretholes
US5677457A (en) * 1996-12-19 1997-10-14 Hoechst Marion Roussel, Inc. Method of preparation of physostigmine carbamate derivatives from eseroline ethers
US6495700B1 (en) * 2002-01-09 2002-12-17 Axonyx, Inc. Process for producing phenserine and its analog
TWI294718B (en) 2005-12-14 2008-03-11 Ind Tech Res Inst Frequency modulation-frequency shift keying (fm/fsk) demodulator

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4791107A (en) * 1986-07-16 1988-12-13 Hoechst-Roussel Pharmaceuticals, Inc. Memory enhancing and analgesic 1,2,3,3A,8,8A-hexahydro-3A,8 (and) 1,3A,8)-di(and tri)methylpyrrolo(2,3-B)indoles, compositions and use
IT1225462B (it) * 1987-04-03 1990-11-14 Mediolanum Farmaceutici Srl Sali organici di derivati della fisostigmina
US4900748A (en) * 1988-03-04 1990-02-13 The United States Of America As Represented By The Department Of Health And Human Services Carbamates related to (-)-physostigmine as cholinergic agents
US4914102A (en) * 1989-09-28 1990-04-03 Hoechst Roussel Pharmaceuticals, Inc. N-aminocarbamates related to physostigmine, pharmacentical compositions and use
US5077289A (en) * 1989-11-30 1991-12-31 Hoechst Roussel Pharmaceuticals Inc. Memory enhancing and analgesic aminocarbonylcarbamates related to physostigmine

Also Published As

Publication number Publication date
NO301276B1 (no) 1997-10-06
AU660550B2 (en) 1995-06-29
JP2899502B2 (ja) 1999-06-02
TW239143B (fi) 1995-01-21
PH30885A (en) 1997-12-23
NO932616D0 (no) 1993-07-20
IL106419A (en) 1999-12-31
JPH09176167A (ja) 1997-07-08
JPH06179678A (ja) 1994-06-28
CN1037443C (zh) 1998-02-18
CN1084174A (zh) 1994-03-23
AU4204993A (en) 1994-01-27
FI933264A (fi) 1994-01-22
NO932616L (no) 1994-01-24
US5498726A (en) 1996-03-12
HU212600B (en) 1996-09-30
CA2100908A1 (en) 1994-01-22
KR940005629A (ko) 1994-03-22
HUT65135A (en) 1994-04-28
JP2949085B2 (ja) 1999-09-13
CZ147393A3 (en) 1994-03-16
RU2116307C1 (ru) 1998-07-27
MX9304397A (es) 1994-02-28
FI990752A0 (fi) 1999-04-06
HU9302110D0 (en) 1993-11-29
FI933264A0 (fi) 1993-07-19
IL106419A0 (en) 1993-11-15
NZ248180A (en) 1995-02-24
CZ284321B6 (cs) 1998-10-14

Similar Documents

Publication Publication Date Title
FI980631A (fi) Menetelmä klavulaanihapon valmistamiseksi
FI103666B1 (fi) Menetelmä bifenyylijohdannaisen valmistamiseksi
FI940769A0 (fi) Menetelmä 2-aminoatsolijohdannaisten valmistamiseksi
FI952585A0 (fi) Menetelmä bentsopyraaniyhdisteiden valmistamiseksi
FI104075B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten 2-karboksitienyylikarbamoyylipyrrolidin-4-yylitiokarbapeneemi-3-karboksyylihappojohdannaisten valmistamiseksi
NZ248179A (en) Process for the preparation of physostigmine carbamate derivatives
FI98461B (fi) Menetelmä terapeuttisesti käyttökelpoisten yhdisteiden valmistamiseksi
FI911701A (fi) Menetelmä terapeuttisesti käyttökelpoisten 2-substituoitujen alkyyli-3-karboksikarbapeneemien valmistamiseksi
NO179517C (no) Fremgangsmåte for fremstilling av 8-klorkinolonderivater
FI990752A (fi) Menetelmä fysostigmiinikarbamaattijohdannaisten valmistamiseksi fysostigmiinistä
FI956058A (fi) Menetelmä glutaaridialdehydin valmistamiseksi
FI953361A0 (fi) Menetelmä substituoitujen indolonijohdannaisten valmistamiseksi
FI943833A (fi) Menetelmä 2,3,5,6-tetraklooripyridiinin valmistamiseksi
FI102841B1 (fi) Menetelmä mannitolin valmistamiseksi
FI940551A0 (fi) Menetelmä fenyylibentsamidijohdannaisten valmistamiseksi
FI974027A0 (fi) Menetelmä fysostigmiinikarbamaattijohdannaisten valmistamiseksi eseretoleista
FI971964A0 (fi) Menetelmä 1-halo-3-trialkyylisilasnyylibentseenijohdannaisten valmistamiseksi
FI953181A (fi) Puriinien valmistusmenetelmä
FI97885B (fi) Menetelmä terapeuttisesti aktiivisten nojirimysiinijohdannaisten valmistamiseksi
NO963084L (no) Fremgangsmåte for fremstilling av pyrrolidinyl-acetamidderivater
FI901604A0 (fi) Uusien tieno-triatsolo-diatsepiinien valmistusmenetelmä
FI944128A0 (fi) Menetelmä N-(2-pyrimidyyli)piperatsinyyli-butyyli-imidien valmistamiseksi
FI953443A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 4-amino-3-isoksatsolidinonien ja 3-amino-1-hydroksipyrroilidin-2-onien karbamaattijohdannaisten valmistamiseksi
FI962714A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten naftyridiinijohdannaisten valmistamiseksi
FI942927A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten tetrahydronaftaleenijohdannaisten valmistamiseksi